{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:12:16Z","timestamp":1779300736174,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109299","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:01Z","timestamp":1779299881000},"source":"Crossref","is-referenced-by-count":0,"title":["Changes in Serum Testosterone After Sublingual Enclomiphene Citrate Combined With a Mineral Oxide Delivery System: A Retrospective Case Series of 15 Men"],"prefix":"10.7759","author":[{"given":"Steven","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1375","article-title":"A population-level decline in serum testosterone levels in American men","volume":"92","author":"Travison TG","year":"2007","unstructured":"Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007, 92:196-202. 10.1210\/jc.2006-1375","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.02.006","article-title":"Decline in serum testosterone levels among adolescent and young adult men in the USA","volume":"7","author":"Lokeshwar SD","year":"2021","unstructured":"Lokeshwar SD, Patel P, Fantus RJ, et al.. Decline in serum testosterone levels among adolescent and young adult men in the USA. Eur Urol Focus. 2021, 7:886-9. 10.1016\/j.euf.2020.02.006","journal-title":"Eur Urol Focus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00575-2","article-title":"Secular trends in testosterone\u2014findings from a large state-mandate care provider","volume":"18","author":"Chodick G","year":"2020","unstructured":"Chodick G, Epstein S, Shalev V. Secular trends in testosterone\u2014findings from a large state-mandate care provider. Reprod Biol Endocrinol. 2020, 18:19. 10.1186\/s12958-020-00575-2","journal-title":"Reprod Biol Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001078","article-title":"Effect of Natesto on reproductive hormones, semen parameters and hypogonadal symptoms: a single center, open label, single arm trial","volume":"204","author":"Ramasamy R","year":"2020","unstructured":"Ramasamy R, Masterson TA, Best JC, et al.. Effect of Natesto on reproductive hormones, semen parameters and hypogonadal symptoms: a single center, open label, single arm trial. J Urol. 2020, 204:557-63. 10.1097\/JU.0000000000001078","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0802","article-title":"Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression","volume":"90","author":"Coviello AD","year":"2005","unstructured":"Coviello AD, Matsumoto AM, Bremner WJ, et al.. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005, 90:2595-602. 10.1210\/jc.2004-0802","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-77779-1_6","article-title":"Leydig cell and spermatogenesis","volume":"1288","author":"Ge RS","year":"2021","unstructured":"Ge RS, Li X, Wang Y. Leydig cell and spermatogenesis. Adv Exp Med Biol. 2021, 1288:111-29. 10.1007\/978-3-030-77779-1_6","journal-title":"Adv Exp Med Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13337","article-title":"Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement","volume":"117","author":"Kim ED","year":"2016","unstructured":"Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. 2016, 117:677-85. 10.1111\/bju.13337","journal-title":"BJU Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12363","article-title":"Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics","volume":"112","author":"Wiehle R","year":"2013","unstructured":"Wiehle R, Cunningham GR, Pitteloud N, et al.. Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU Int. 2013, 112:1188-200. 10.1111\/bju.12363","journal-title":"BJU Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.06.004","article-title":"Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a\u00a0randomized phase II clinical trial comparing topical testosterone","volume":"102","author":"Wiehle RD","year":"2014","unstructured":"Wiehle RD, Fontenot GK, Wike J, et al.. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a\u00a0randomized phase II clinical trial comparing topical testosterone. Fertil Steril. 2014, 102:720-7. 10.1016\/j.fertnstert.2014.06.004","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/iju.IJU_372_16","article-title":"Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men","volume":"33","author":"Dadhich P","year":"2017","unstructured":"Dadhich P, Ramasamy R, Scovell J, Wilken N, Lipshultz L. Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men. Indian J Urol. 2017, 33:236-40. 10.4103\/iju.IJU_372_16","journal-title":"Indian J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/tau-24-238","article-title":"Safety and efficacy of enclomiphene and clomiphene for hypogonadal men","volume":"13","author":"Saffati G","year":"2024","unstructured":"Saffati G, Kassab J, Orozco Rendon D, et al.. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Transl Androl Urol. 2024, 13:1984-90. 10.21037\/tau-24-238","journal-title":"Transl Androl Urol"},{"key":"ref12","unstructured":"Guidance regarding methods for de-identification of protected health information in accordance with the HIPAA privacy rule. (2012). https.\/\/www.hhs.gov\/hipaa\/for-professionals\/privacy\/special-topics\/de-identification\/index.html."},{"key":"ref13","article-title":"Nothing boring about boron","volume":"14","author":"Pizzorno L","year":"2015","unstructured":"Pizzorno L. Nothing boring about boron. Integr Med (Encinitas). 2015, 14:35-48.","journal-title":"Integr Med (Encinitas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2010.10.001","article-title":"Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines","volume":"25","author":"Naghii MR","year":"2011","unstructured":"Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Elem Med Biol. 2011, 25:54-8. 10.1016\/j.jtemb.2010.10.001","journal-title":"J Trace Elem Med Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062753","article-title":"Spermidine as a potential protective agents against poly(i:c)-induced immune response, oxidative stress, apoptosis, and testosterone decrease in yak Leydig cells","volume":"26","author":"Tang Y","year":"2025","unstructured":"Tang Y, Li H, Zeng Y, et al.. Spermidine as a potential protective agents against poly(i:c)-induced immune response, oxidative stress, apoptosis, and testosterone decrease in yak Leydig cells. Int J Mol Sci. 2025, 26:2753. 10.3390\/ijms26062753","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan2788","article-title":"Spermidine in health and disease","volume":"359","author":"Madeo F","year":"2018","unstructured":"Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science. 2018, 359:2788. 10.1126\/science.aan2788","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1975","article-title":"Induction of autophagy by spermidine promotes longevity","volume":"11","author":"Eisenberg T","year":"2009","unstructured":"Eisenberg T, Knauer H, Schauer A, et al.. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009, 11:1305-14. 10.1038\/ncb1975","journal-title":"Nat Cell Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01468-x","article-title":"Spermidine is essential for fasting-mediated autophagy and longevity","volume":"26","author":"Hofer SJ","year":"2024","unstructured":"Hofer SJ, Daskalaki I, Bergmann M, et al.. Spermidine is essential for fasting-mediated autophagy and longevity. Nat Cell Biol. 2024, 26:1571-84. 10.1038\/s41556-024-01468-x","journal-title":"Nat Cell Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin S","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, et al.. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018, 103:1715-44. 10.1210\/jc.2018-00229","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2307\/2333709","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro SS","year":"1965","unstructured":"Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965, 52:591-611. 10.2307\/2333709","journal-title":"Biometrika"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2015.68.6.540","article-title":"T test as a parametric statistic","volume":"68","author":"Kim TK","year":"2015","unstructured":"Kim TK. T test as a parametric statistic. Korean J Anesthesiol. 2015, 68:540-6. 10.4097\/kjae.2015.68.6.540","journal-title":"Korean J Anesthesiol"},{"key":"ref22","article-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen J","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. Routledge, New York (NY); 1988."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2307\/3001968","article-title":"Individual comparisons by ranking methods","volume":"1","author":"Wilcoxon F","year":"1945","unstructured":"Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bull. 1945, 1:80-3. 10.2307\/3001968","journal-title":"Biometrics Bull"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614548680","article-title":"Adverse effects of testosterone replacement therapy: an update on the evidence and controversy","volume":"5","author":"Grech A","year":"2014","unstructured":"Grech A, Breck J, Heidelbaugh J. Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Ther Adv Drug Saf. 2014, 5:190-200. 10.1177\/2042098614548680","journal-title":"Ther Adv Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477576-changes-in-serum-testosterone-after-sublingual-enclomiphene-citrate-combined-with-a-mineral-oxide-delivery-system-a-retrospective-case-series-of-15-men","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:04Z","timestamp":1779299884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477576-changes-in-serum-testosterone-after-sublingual-enclomiphene-citrate-combined-with-a-mineral-oxide-delivery-system-a-retrospective-case-series-of-15-men"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.109299","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}